Latest Diabetes News
Effect estimates are much more significant for individuals diagnosed with prediabetes.
Trajectories in eGRF decline were linear for about 87% of patients, accelerating for 6%.
Study confirms the noninferiority of semaglutide.
Findings in American-Indians with type 2 diabetes and urine albumin/creatinine ratio 300 mg/g
Patients with diabetes had a significant 42% increased risk of recurrence of cancer and 79% increased risk of progression.
AGEs improve RFL prediction in American-Indians with type 2 diabetes.
No change in effective renal plasma flow, other intrarenal hemodynamic measures.
Add-on mineralocorticoid receptor antagonist therapy increased serum potassium by 0.4 mEq.
Risk for CV events and microvascular (with exception of peripheral neuropathy) complications down.
At 24 weeks, greater HbA1c reductions were seen with combination empagliflozin + metformin therapy.
Researchers suggest steaming, poaching, and stewing for better health.
Findings in African-American patients with new-onset diabetic ketoacidosis and severe hyperglycemia.
Researchers found that HbA1c was reduced by 1.2% at 6 months among study participants.
Metformin-associated 1-year risk of acute dialysis increased by 50.3 per 100,000 individuals.
Significantly higher nighttime systolic blood pressure, especially in patients with diabetes and low eGFR.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)